Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 195

1.

Venous Thromboembolism Prophylaxis in Orthopedic Surgery [Internet].

Sobieraj DM, Coleman CI, Tongbram V, Lee S, Colby J, Chen WT, Makanji SS, Ashaye A, Kluger J, White CM.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2012 Mar.

2.

Is routine chemical thromboprophylaxis after total hip replacement really necessary in a Japanese population?

Yokote R, Matsubara M, Hirasawa N, Hagio S, Ishii K, Takata C.

J Bone Joint Surg Br. 2011 Feb;93(2):251-6. doi: 10.1302/0301-620X.93B2.25795.

PMID:
21282767
3.

A critical appraisal of bleeding events reported in venous thromboembolism prevention trials of patients undergoing hip and knee arthroplasty.

Dahl OE, Quinlan DJ, Bergqvist D, Eikelboom JW.

J Thromb Haemost. 2010 Sep;8(9):1966-75. doi: 10.1111/j.1538-7836.2010.03965.x. Review.

4.

Comparing the quality of care across Belgian hospitals from medical basic datasets: the case of thromboembolism prophylaxis after major orthopaedic surgery.

Gerkens S, Crott R, Closon MC, Horsmans Y, Beguin C.

J Eval Clin Pract. 2010 Aug;16(4):685-92. doi: 10.1111/j.1365-2753.2009.01175.x. Epub 2010 Jun 10.

PMID:
20545808
5.

Dabigatran versus enoxaparin for prevention of venous thromboembolism after hip or knee arthroplasty: a pooled analysis of three trials.

Friedman RJ, Dahl OE, Rosencher N, Caprini JA, Kurth AA, Francis CW, Clemens A, Hantel S, Schnee JM, Eriksson BI; RE-MOBILIZE, RE-MODEL, RE-NOVATE Steering Committees.

Thromb Res. 2010 Sep;126(3):175-82. doi: 10.1016/j.thromres.2010.03.021. Epub 2010 May 15.

PMID:
20434759
7.

Symptomatic venous thromboembolism following a hip fracture.

McNamara I, Sharma A, Prevost T, Parker M.

Acta Orthop. 2009 Dec;80(6):687-92. doi: 10.3109/17453670903448273.

8.

Major bleeding, mortality, and efficacy of fondaparinux in venous thromboembolism prevention trials.

Eikelboom JW, Quinlan DJ, O'Donnell M.

Circulation. 2009 Nov 17;120(20):2006-11. doi: 10.1161/CIRCULATIONAHA.109.872630. Epub 2009 Nov 2.

9.

Dabigatran etexilate prevents venous thromboembolism after total knee arthroplasty in Japanese patients with a safety profile comparable to placebo.

Fuji T, Fuijita S, Ujihira T, Sato T.

J Arthroplasty. 2010 Dec;25(8):1267-74. doi: 10.1016/j.arth.2009.08.010. Epub 2009 Oct 25.

PMID:
19854610
10.

Metabolic syndrome and the incidence of symptomatic deep vein thrombosis following total knee arthroplasty.

Gandhi R, Razak F, Tso P, Davey JR, Mahomed NN.

J Rheumatol. 2009 Oct;36(10):2298-301. doi: 10.3899/jrheum.090282. Epub 2009 Aug 14.

PMID:
19684153
11.

Does aspirin have a role in venous thromboembolism prophylaxis in total knee arthroplasty patients?

Bozic KJ, Vail TP, Pekow PS, Maselli JH, Lindenauer PK, Auerbach AD.

J Arthroplasty. 2010 Oct;25(7):1053-60. doi: 10.1016/j.arth.2009.06.021. Epub 2009 Aug 12.

12.

Is a tourniquet beneficial in total knee replacement surgery? A meta-analysis and systematic review.

Smith TO, Hing CB.

Knee. 2010 Mar;17(2):141-7. doi: 10.1016/j.knee.2009.06.007. Epub 2009 Jul 19. Review.

PMID:
19616954
13.

AHRQ series paper 5: grading the strength of a body of evidence when comparing medical interventions--agency for healthcare research and quality and the effective health-care program.

Owens DK, Lohr KN, Atkins D, Treadwell JR, Reston JT, Bass EB, Chang S, Helfand M.

J Clin Epidemiol. 2010 May;63(5):513-23. doi: 10.1016/j.jclinepi.2009.03.009.

PMID:
19595577
14.

American academy of orthopaedic surgeons clinical practice guideline on. Prevention of symptomatic pulmonary embolism in patients undergoing total hip or knee arthroplasty.

Johanson NA, Lachiewicz PF, Lieberman JR, Lotke PA, Parvizi J, Pellegrini V, Stringer TA, Tornetta P 3rd, Haralson RH 3rd, Watters WC 3rd.

J Bone Joint Surg Am. 2009 Jul;91(7):1756-7. doi: 10.2106/JBJS.I.00511. No abstract available.

PMID:
19571100
15.

A comparison of regional and general anaesthesia for total replacement of the hip or knee: a meta-analysis.

Hu S, Zhang ZY, Hua YQ, Li J, Cai ZD.

J Bone Joint Surg Br. 2009 Jul;91(7):935-42. doi: 10.1302/0301-620X.91B7.21538. Review.

PMID:
19567860
16.

Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial.

Turpie AG, Lassen MR, Davidson BL, Bauer KA, Gent M, Kwong LM, Cushner FD, Lotke PA, Berkowitz SD, Bandel TJ, Benson A, Misselwitz F, Fisher WD; RECORD4 Investigators.

Lancet. 2009 May 16;373(9676):1673-80. doi: 10.1016/S0140-6736(09)60734-0. Epub 2009 May 4.

17.

The incidence of fatal pulmonary embolism after primary hip and knee replacement in a consecutive series of 4253 patients.

Cusick LA, Beverland DE.

J Bone Joint Surg Br. 2009 May;91(5):645-8. doi: 10.1302/0301-620X.91B5.21939.

PMID:
19407300
18.

Thromboembolic prophylaxis for total knee arthroplasty in Asian patients: a randomised controlled trial.

Chin PL, Amin MS, Yang KY, Yeo SJ, Lo NN.

J Orthop Surg (Hong Kong). 2009 Apr;17(1):1-5.

19.

A systematic review of thromboprophylaxis for pelvic and acetabular fractures.

Slobogean GP, Lefaivre KA, Nicolaou S, O'Brien PJ.

J Orthop Trauma. 2009 May-Jun;23(5):379-84. doi: 10.1097/BOT.0b013e3181a5369c. Review.

PMID:
19390367

Supplemental Content

Support Center